Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Is the reduction of lower-body subcutaneous adipose tissue associated with elevations in risk factors for diabetes and cardiovascular disease?

Janiszewski PM, Kuk JL, Ross R.

Diabetologia. 2008 Aug;51(8):1475-82. doi: 10.1007/s00125-008-1058-0. Epub 2008 Jun 6.

PMID:
18535815
2.

Associations between breast adipose tissue, body fat distribution and cardiometabolic risk in women: cross-sectional data and weight-loss intervention.

Schautz B, Later W, Heller M, Müller MJ, Bosy-Westphal A.

Eur J Clin Nutr. 2011 Jul;65(7):784-90. doi: 10.1038/ejcn.2011.35. Epub 2011 Mar 23.

PMID:
21427743
3.

Breast volume is an independent predictor of visceral and ectopic fat in premenopausal women.

Janiszewski PM, Saunders TJ, Ross R.

Obesity (Silver Spring). 2010 Jun;18(6):1183-7. doi: 10.1038/oby.2009.336. Epub 2009 Oct 22.

4.

Impact of abdominal visceral and subcutaneous adipose tissue on cardiometabolic risk factors: the Jackson Heart Study.

Liu J, Fox CS, Hickson DA, May WD, Hairston KG, Carr JJ, Taylor HA.

J Clin Endocrinol Metab. 2010 Dec;95(12):5419-26. doi: 10.1210/jc.2010-1378. Epub 2010 Sep 15.

5.
6.

Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study.

Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, Vasan RS, Murabito JM, Meigs JB, Cupples LA, D'Agostino RB Sr, O'Donnell CJ.

Circulation. 2007 Jul 3;116(1):39-48. Epub 2007 Jun 18.

7.

Effects of dietary treatment alone or diet with voglibose or glyburide on abdominal adipose tissue and metabolic abnormalities in patients with newly diagnosed type 2 diabetes.

Takami K, Takeda N, Nakashima K, Takami R, Hayashi M, Ozeki S, Yamada A, Kokubo Y, Sato M, Kawachi S, Sasaki A, Yasuda K.

Diabetes Care. 2002 Apr;25(4):658-62.

PMID:
11919121
8.

Association between exercise-induced change in body composition and change in cardiometabolic risk factors in postmenopausal South Asian women.

Lesser IA, Guenette JA, Hoogbruin A, Mackey DC, Singer J, Gasevic D, Lear SA.

Appl Physiol Nutr Metab. 2016 Sep;41(9):931-7. doi: 10.1139/apnm-2016-0082. Epub 2016 Apr 28.

PMID:
27507007
9.
10.

Visceral/epicardial adiposity in nonobese and apparently healthy young adults: association with the cardiometabolic profile.

De Larochellière E, Côté J, Gilbert G, Bibeau K, Ross MK, Dion-Roy V, Pibarot P, Després JP, Larose E.

Atherosclerosis. 2014 May;234(1):23-9. doi: 10.1016/j.atherosclerosis.2014.01.053. Epub 2014 Feb 7.

PMID:
24589564
11.
12.

Visceral and not subcutaneous abdominal adiposity reduction drives the benefits of a 1-year lifestyle modification program.

Borel AL, Nazare JA, Smith J, Alméras N, Tremblay A, Bergeron J, Poirier P, Després JP.

Obesity (Silver Spring). 2012 Jun;20(6):1223-33. doi: 10.1038/oby.2011.396. Epub 2012 Jan 19.

13.

Visceral fat and race-dependent health risks in obese nondiabetic premenopausal women.

Albu JB, Murphy L, Frager DH, Johnson JA, Pi-Sunyer FX.

Diabetes. 1997 Mar;46(3):456-62.

PMID:
9032103
14.

Association of abdominal fat distribution and cardiometabolic risk factors among obese Korean adolescents.

Kim JA, Park HS.

Diabetes Metab. 2008 Apr;34(2):126-30. doi: 10.1016/j.diabet.2007.10.012. Epub 2008 Mar 4.

PMID:
18289908
15.

Improvement of glucose and lipid metabolism associated with selective reduction of intra-abdominal visceral fat in premenopausal women with visceral fat obesity.

Fujioka S, Matsuzawa Y, Tokunaga K, Kawamoto T, Kobatake T, Keno Y, Kotani K, Yoshida S, Tarui S.

Int J Obes. 1991 Dec;15(12):853-9.

PMID:
1794928
16.

Exercise is required for visceral fat loss in postmenopausal women with type 2 diabetes.

Giannopoulou I, Ploutz-Snyder LL, Carhart R, Weinstock RS, Fernhall B, Goulopoulou S, Kanaley JA.

J Clin Endocrinol Metab. 2005 Mar;90(3):1511-8. Epub 2004 Dec 14.

PMID:
15598677
17.

Weight-loss diet alone or combined with progressive resistance training induces changes in association between the cardiometabolic risk profile and abdominal fat depots.

García-Unciti M, Izquierdo M, Idoate F, Gorostiaga E, Grijalba A, Ortega-Delgado F, Martínez-Labari C, Moreno-Navarrete JM, Forga L, Fernández-Real JM, Ibáñez J.

Ann Nutr Metab. 2012;61(4):296-304. doi: 10.1159/000342467. Epub 2012 Dec 3.

18.

Abdominal Fat Distribution and Cardiovascular Risk in Men and Women With Different Levels of Glucose Tolerance.

Scheuer SH, Færch K, Philipsen A, Jørgensen ME, Johansen NB, Carstensen B, Witte DR, Andersen I, Lauritzen T, Andersen GS.

J Clin Endocrinol Metab. 2015 Sep;100(9):3340-7. doi: 10.1210/JC.2014-4479. Epub 2015 Jun 29.

PMID:
26120787
19.

Are gender differences in cardiovascular disease risk factors explained by the level of visceral adipose tissue?

Lemieux S, Després JP, Moorjani S, Nadeau A, Thériault G, Prud'homme D, Tremblay A, Bouchard C, Lupien PJ.

Diabetologia. 1994 Aug;37(8):757-64.

PMID:
7988777
20.

Contribution of visceral obesity to the deterioration of the metabolic risk profile in men with impaired glucose tolerance.

Pascot A, Després JP, Lemieux I, Bergeron J, Nadeau A, Prud'homme D, Tremblay A, Lemieux S.

Diabetologia. 2000 Sep;43(9):1126-35.

PMID:
11043858

Supplemental Content

Support Center